New Strategies for the Treatment of Advanced-Stage Hodgkin's Lymphoma
Authors:
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 21 (5) , 897-914
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Randomized Trial by the Intergruppo Italiano LinfomiJournal of Clinical Oncology, 2005
- High-Dose Therapy and Autologous Stem-Cell Transplantation Versus Conventional Therapy for Patients With Advanced Hodgkin’s Lymphoma Responding to Front-Line TherapyJournal of Clinical Oncology, 2003
- 14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study GroupJournal of Clinical Oncology, 2003
- Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup TrialJournal of Clinical Oncology, 2003
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Hodgkin's disease — the role of radiation therapy in advanced diseaseAnnals of Oncology, 1996
- Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's diseaseAnnals of Oncology, 1996
- The Case for Adjuvant Radiation Therapy in Advanced Hodgkin's DiseaseCancer Investigation, 1996
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975